Gene Expression Differences Predict Treatment Outcome of Merkel Cell Carcinoma Patients
Due to the rarity of Merkel cell carcinoma (MCC), prospective clinical trials have not been practical. This study aimed to identify biomarkers with prognostic significance. While sixty-two patients were identified who were treated for MCC at our institution, only seventeen patients had adequate form...
Saved in:
Main Authors: | Loren Masterson, Bryan J. Thibodeau, Laura E. Fortier, Timothy J. Geddes, Barbara L. Pruetz, Rajwant Malhotra, Richard Keidan, George D. Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Skin Cancer |
Online Access: | http://dx.doi.org/10.1155/2014/596459 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vulvar Merkel Carcinoma: A Case Report
by: C. Iavazzo, et al.
Published: (2011-01-01) -
Characterization of the Merkel Cell Carcinoma miRNome
by: Matthew S. Ning, et al.
Published: (2014-01-01) -
Which Are the Cells of Origin in Merkel Cell Carcinoma?
by: Thomas Tilling, et al.
Published: (2012-01-01) -
Merkel Cell Carcinoma: The Past, the Present, and the Future
by: Inamaria Erovic, et al.
Published: (2013-01-01) -
Merkel Cell Carcinoma of the Retroperitoneum with No Identifiable Primary Site
by: Daniele Rossini, et al.
Published: (2013-01-01)